Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Gaceta Médica Espirituana
versión On-line ISSN 1608-8921
Resumen
DESTEN RAMOS, Alicia; RAMIREZ MORAN, Angel Florencio; GRAVE DE PERALTA, Randhol Scott y WILSON CHIBAS, Francisca María. Heberprot-P® in diabetic foot ulcer. "Emilio Daudinot Bueno" University Polyclinic. Gac Méd Espirit [online]. 2020, vol.22, n.3, pp. 44-53. Epub 03-Dic-2020. ISSN 1608-8921.
Background:
Heberprot-P® is a healing product for diabetic foot ulcer; this medication is used at Emilio Daudinot Bueno University Polyclinic in Guantánamo; so, a greater knowledge about scientific elements is necessary for its practical application with a comprehensive perspective.
Objective:
To describe the behavior of the use of Heberprot-P® in patients with diabetic foot ulcer at Emilio Daudinot Bueno University Polyclinic in Guantánamo municipality, from January 2017 to December 2018.
Methodology:
A descriptive observational study was carried out; the universe consisted of 140 patients who had the inclusion criteria: belonging to the health area and attending the diabetic foot ulcer clinic at the polyclinic. The information was obtained from the medical records of the assisted patients.
Results:
The age group 65-74 years, female sex, type 2 diabetes mellitus, smoking as a fundamental risk factor and with an etiological diagnosis of neuroinfectious diabetic foot ulcer and Wagner type 2 prevailed. It was not detected in most of the patients some adverse reaction when applying the medication.
Conclusions:
Most of the assisted patients evolved satisfactorily, this assures the effectiveness of Heberprot-P®.
Palabras clave : Heberprot-P®; diabetic foot; risk factors; diabetes mellitus type 2.